Deleted Journal,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 20, 2025
Die
Pathophysiologie
chronisch-entzündlicher
Darmerkrankungen
(CED)
ist
nicht
vollständig
geklärt.
In
einem
Stufenmodell
der
European
Crohn's
and
Colitis
Organisation
(ECCO)
zur
Krankheitsentstehung
wird
von
Risikopersonenkollektiv
ausgegangen,
in
dem
sich
über
subtile
Veränderungen
im
Verlauf
die
Erkrankung
manifestiert.
Zusammenfassung
des
aktuellen
Erkenntnisstands
Pathophysiologie,
Prädiktion
und
Prävention
CED.
Selektive
Literaturrecherche
via
PubMed.
Mehrere
genetische,
biochemische
mikrobiombezogene
Scores
haben
das
Potenzial,
Personen
zu
identifizieren,
ein
erhöhtes
Risiko
Entwicklung
einer
CED
aufweisen,
dies
teils
bis
Jahrzehnt
vor
Manifestation.
zunehmenden
Kenntnisse
Pathogenese
machen
Manifestation
solchen
möglichen,
zukünftigen
Diagnoseziel.
Hypothetisch
sind
frühe
manifester
reversibel
könnten
Präventionsprogrammen
zugänglich
gemacht
werden.
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: March 4, 2025
Ulcerative
colitis
is
an
idiopathic
gastrointestinal
disease
described
by
chronic
inflammation
of
the
digestive
system.
Cytokines
may
be
responsible
for
immunopathogenesis,
mucosal
and
tissue
damage,
even
treatment
response.
In
addition
to
its
role
in
calcium
phosphorus
homeostasis
bone
health,
vitamin
D
immunomodulatory
anti-inflammatory
agent.
Understanding
cytokines
lead
improving
pathogenesis
this
disease,
therefore
we
aimed
investigate
relative
gene
expression
pro-
biopsy
samples
taken
from
affected
area
colon
ulcerative
patients
association
with
serum
levels.
A
total
47
were
enrolled
case-control
study.
The
case
group
consisted
23
treatment-resistant
colitis,
control
24
responding
routine
treatment.
Serum
levels
measured
ELISA
method.
Real-time
PCR
was
employed
quantify
groups.
pro-inflammatory
included
tumor
necrosis
factor-α
(TNF-α),
interferon-gamma
(IFN-γ),
interleukin-1β
(IL-1β),
IL-6,
IL-8,
IL-17
A,
IL-33,
while
IL-10,
IL-35,
TGF-β.
Data
are
showed
as
mean
±
standard
deviation
(SD),
p
values
<
0.05
considered
statistically
significant.
age
45.88
18.51
years,
that
41.30
13.01
years.
TNF-α,
IFN-γ,
IL-1β,
TGF-β,
groups
did
not
exhibit
significant
differences
(p
>
0.05).
However,
principal
cytokines,
including
elevated
compared
who
responded
treatments.
No
correlation
observed
between
present
study
identify
a
or
Therefore,
treatments
had
no
effect
on
these
patients.
Additionally,
related
Despite
need
further
research
protective
pathological
roles
D,
regular
screening
early
complementary
beneficial
reducing
inflammatory
symptoms
Physiology,
Journal Year:
2024,
Volume and Issue:
40(1), P. 000 - 000
Published: July 30, 2024
Inflammation
is
an
important
physiological
response
of
the
organism
to
restore
homeostasis
upon
pathogenic
or
damaging
stimuli.
However,
persistence
harmful
trigger
a
deficient
resolution
process
can
evolve
into
state
low-grade,
chronic
inflammation.
This
condition
strongly
associated
with
development
several
increasingly
prevalent
and
serious
conditions,
such
as
obesity,
cancer,
cardiovascular
diseases,
elevating
overall
morbidity
mortality
worldwide.
The
current
pandemic
diseases
underscores
need
address
inflammation,
its
mechanisms,
potential
preventive
measures
limit
widespread
impact.
present
review
discusses
knowledge
research
gaps
regarding
association
between
low-grade
inflammation
focusing
on
digestive
cancer.
We
examine
art
in
selected
aspects
topic
propose
future
directions
approaches
for
field.
Foods,
Journal Year:
2025,
Volume and Issue:
14(1), P. 137 - 137
Published: Jan. 6, 2025
Background:
Ulcerative
colitis
(UC)
is
a
chronic
intestinal
disease
of
growing
global
concern.
Bacteria
associated
with
fermented
food
or
probiotics
regulate
immune
and
inflammatory
responses,
playing
key
role
in
homeostasis.
Results:
Five
relatively
good
antioxidant
effects,
namely
Lactiplantibacillus
plantarum
H6,
Latilactobacillus
sakei
QC9,
Limosilactobacillus
fermentum
E7,
Bacillus
subtills
D1,
licheniformis
Q13,
were
screened
out
from
30
strains
through
vitro
assays.
The
five
had
varying
degrees
alleviating
effects
on
UC
mice
improved
various
physiological
indicators,
such
as
oxidative
stress
parameters
histopathological
sections.
Q13
more
pronounced.
Furthermore,
E7
effectively
regulated
mouse
microbiota
composition,
increased
short-chain
fatty
acid
concentration,
promoted
the
expression
anti-inflammatory
factors,
interleukin
10
(IL-10),
while
suppressing
that
pro-inflammatory
1β
(IL-1β),
6
(IL-6),
tumor
necrosis
factor
α
(TNF-α).
Meanwhile,
D1
only
exhibited
partial
effects.
Finally,
tight
junction
proteins
colon
tissues.
Conclusions:
showed
superior
efficacy
to
other
UC,
offering
novel
therapeutic
prospects
for
safer
effective
management
UC.
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: Jan. 7, 2025
The
aim
was
to
explore
factors
associated
with
intestinal
tissue
levels
of
anti-TNF
alpha
(anti-TNF),
antibodies,
and
cytokines
in
pediatric
patients
Crohn
Disease
(CD).
In
a
prospective
exploratory
study
CD
undergoing
ileocecal
resection
or
colonoscopy
between
6/2020
1/2023,
we
analysed
anti-TNF,
(TNF-α,
IL-17,
IL-1β,
IFN-γ)
from
biopsies.
Mixed-effects
regression
models,
adjusted
for
potential
confounders,
were
used.
Data
27
(18
females,
66.7%)
analysed.
Fourteen
(52%)
received
adalimumab
(ADA)
thirteen
infliximab
(IFX),
median
therapy
duration
17
(IQR
4.5–41.5)
months.
Higher
free
found
macroscopically
inflamed
compared
non-inflamed
(β
=
3.42,
95%
CI
1.05–6.10).
No
significant
association
serum
(β=
−0.06,
−
0.70–0.58).
Patients
treated
longer
had
increased
IL-17
0.19,
0.05–0.33),
independent
disease
age.
IFN-γ
linked
both
follow-up
length.
Our
shows
significantly
higher
drug
tissue.
Long-term
treatment
has
been
levels,
suggesting
possible
impact
on
the
cytokine
response
pathway.
We
did
not
observe
relationship
levels.
Frontiers in Microbiology,
Journal Year:
2025,
Volume and Issue:
15
Published: Jan. 7, 2025
Gut
microbiota
dysbiosis
significantly
impacts
ulcerative
colitis
(UC)
progression
and
exacerbation.
Probiotics
show
promise
in
UC
management.
This
study
evaluated
the
effects
of
different
doses
Bacillus
pumilus
LV149,
an
aquatic-derived
probiotic,
on
gut
injury
repair
male
C57BL/6
mice
with
dextran
sulfate
sodium
(DSS)-induced
investigated
underlying
mechanisms.
was
induced
by
allowing
free
access
to
a
3%
DSS
solution
for
7
days,
concurrent
daily
oral
gavage
either
low
(LV149-L,
1
×
108
CFU/day/mouse)
or
high
(LV149-H,
109
dose
LV149.
The
were
assessed
through
physiological
parameters,
intestinal
barrier
integrity,
inflammation,
composition,
transcriptomic
changes.
LV149
improved
pathological
symptoms,
including
weight
loss
disease
activity
index
(DAI),
reduced
colon
shortening
dose-dependent
manner
inflammatory
damage.
intervention
also
restored
function
upregulating
mucins,
goblet
cell
counts,
tight
junction
proteins
(ZO-1,
occludin,
claudin-1)
colonic
tissue,
along
reducing
serum
lipopolysaccharide
(LPS)
levels.
Notably,
only
LV149-H
decreased
expression
pro-inflammatory
cytokines
TNF-α,
IL-1β,
IL-6,
while
both
increased
anti-inflammatory
cytokine
IL-10
tissue.
further
modulated
microbiota,
increasing
beneficial
bacteria
pathogenic
populations.
Transcriptomic
analysis
indicated
that
LV149-L
may
exert
via
IL-17
signaling
pathway,
whereas
appears
act
JAK-STAT
pathway.
demonstrated
particularly
at
higher
dose,
effectively
mitigated
DSS-induced
modulating
enhancing
inflammation.
underscored
LV149-H's
potential
as
therapeutic
agent
due
its
stronger
properties
gut-protective
effects.
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: Jan. 15, 2025
PANoptosis
is
one
of
several
modes
programmed
cell
death
(PCD)
and
plays
an
important
role
in
many
inflammatory
immune
diseases.
The
bowel
disease
(IBD)
currently
unknown.
Differentially
expressed
PANoptosis-related
genes
(DE-PRGs)
were
identified,
pathway
enrichment
analyses
performed.
LASSO
regression
model
construction,
a
nomogram
model,
calibration
curves,
ROC
DCA
curves
used
to
evaluate
the
predictive
value
model.
Predicts
transcription
factors
(TFs)
small-molecule
drugs
DE-PRGs
analysed.
Model
immuno-infiltration
features
IBD
include
12
genes:
OGT,
TLR2,
GZMB,
TLR4,
PPIF,
YBX3,
CASP5,
BCL2L1,
CASP6,
MEFV,
GSDMB
BAX.
analysis
suggested
that
these
related
TNF
signalling,
NF-κB,
pyroptosis
necroptosis.
Machine
learning
identified
three
GZMB
CASP5.
have
strong
value.
Immuno-infiltration
revealed
infiltration
was
increased
patients
with
IBD,
closely
various
cells.
TFs
associated
RELA,
NFKB1,
HIF1A,
TP53
SP1.
In
addition,
Connectivity
Map
(CMap)
database
top
10
compounds,
including
buspirone,
chloroquine,
spectinomycin
chlortetracycline.
This
study
indicate
good
ability
for
IBD.
Moreover,
may
mediate
process
through
pyroptosis,
necroptosis
mechanisms.
These
results
present
new
horizon
research
treatment
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: Jan. 30, 2025
Restoration
of
the
intestinal
epithelial
barrier
is
crucial
for
achieving
mucosal
healing,
therapeutic
goal
inflammatory
bowel
disease
(IBD).
During
homeostasis,
renewal
maintained
by
crypt
stem
cells
and
progenitors
that
cease
to
divide
as
they
differentiate
into
mature
colonocytes.
Inflammation
a
major
effector
damage
in
IBD
has
been
found
affect
stemness,
regeneration
cellular
functions.
However,
impact
immune
cell-modulating
drugs
on
homeostasis
repair
poorly
understood.
It
likely
these
will
have
distinct
mechanisms
action
(MOA)
epithelium
relevant
vary
among
patients.
We
investigated
effects
pan-Janus
Kinase
(JAK)
inhibitor
tofacitinib
corticosteroid
budesonide
uninflamed
TNF
+
Poly(I:C)
stimulated
human
colon
organoids
(colonoids)
from
healthy
donors
IBD-patients.
Our
findings
reveal
although
both
exhibit
anti-inflammatory
effects,
increased
colonoid
size
proliferation
during
differentiation,
promoted
stemness.
In
contrast,
decreased
showed
no
consistent
effect
or
study
demonstrates
value
employing
colonoids
investigate
how
inter-individual
variations
healing
personalized
treatment.
Science Advances,
Journal Year:
2025,
Volume and Issue:
11(6)
Published: Feb. 7, 2025
Mucosa-associated
invariant
T
(MAIT)
cells
are
a
large
population
of
unconventional
widely
distributed
in
the
human
gastrointestinal
tract.
Their
homing
to
gut
is
central
maintaining
mucosal
homeostasis
and
immunity.
This
review
discusses
potential
mechanisms
that
guide
MAIT
intestinal
mucosa
during
inflammation,
emphasizing
roles
chemokines,
chemokine
receptors,
tissue
adhesion
molecules.
The
influence
microbiota
on
cell
different
regions
also
discussed.
Last,
we
introduce
how
organoid
technology
offers
potentially
valuable
approach
advance
our
understanding
by
providing
more
physiologically
relevant
model
mimics
tissue.
These
models
may
enable
detailed
investigation
gut-specific
cells.
By
regulation
gut,
avenues
for
therapeutic
interventions
targeting
inflammatory
conditions
such
as
bowel
diseases
(IBD)
emerge.